{"title":"白蛋白与碱性磷酸酶比值在头颈癌预后中的应用：一项系统综述和荟萃分析。","authors":"Yun-Ting Wang, Adarsh Kudva, Yen-Ting Lu, Liang-Tseng Kuo, Chia-Hsuan Lai, Yuan-Hsiung Tsai, Chun-Ta Liao, Ku-Hao Fang, Chung-Jan Kang, Ethan I Huang, Cheng-Ming Hsu, Geng-He Chang, Ming-Shao Tsai, Yao-Te Tsai","doi":"10.21053/ceo.2025-00034","DOIUrl":null,"url":null,"abstract":"<p><p>The prognostic value of pretreatment albumin-to-alkaline phosphatase ratio (AAPR) in head and neck cancer (HNC) remains controversial. This meta-analysis investigated AAPR's predictive potential for survival outcomes in HNC patients. We conducted a comprehensive literature search across EMBASE, Cochrane Library, and PubMed databases through July 30, 2024. Eight studies comprising 1737 HNC patients were analyzed using random-effects models. The analysis revealed that lower AAPR values were significantly correlated with worse overall survival (HR = 2.08), progression-free survival (HR = 2.00), and disease-free survival (HR = 2.18). Sensitivity analyses confirmed result robustness, with no significant publication bias detected. These findings suggest that pretreatment AAPR could serve as a valuable and cost-effective prognostic indicator in HNC, potentially aiding clinicians in risk stratification and treatment decision-making. However, additional validation studies are warranted to confirm its clinical applicability.</p>","PeriodicalId":10318,"journal":{"name":"Clinical and Experimental Otorhinolaryngology","volume":" ","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prognostic utility of albumin-to-alkaline phosphatase ratio in head and neck cancer: A systematic review and metaanalysis.\",\"authors\":\"Yun-Ting Wang, Adarsh Kudva, Yen-Ting Lu, Liang-Tseng Kuo, Chia-Hsuan Lai, Yuan-Hsiung Tsai, Chun-Ta Liao, Ku-Hao Fang, Chung-Jan Kang, Ethan I Huang, Cheng-Ming Hsu, Geng-He Chang, Ming-Shao Tsai, Yao-Te Tsai\",\"doi\":\"10.21053/ceo.2025-00034\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The prognostic value of pretreatment albumin-to-alkaline phosphatase ratio (AAPR) in head and neck cancer (HNC) remains controversial. This meta-analysis investigated AAPR's predictive potential for survival outcomes in HNC patients. We conducted a comprehensive literature search across EMBASE, Cochrane Library, and PubMed databases through July 30, 2024. Eight studies comprising 1737 HNC patients were analyzed using random-effects models. The analysis revealed that lower AAPR values were significantly correlated with worse overall survival (HR = 2.08), progression-free survival (HR = 2.00), and disease-free survival (HR = 2.18). Sensitivity analyses confirmed result robustness, with no significant publication bias detected. These findings suggest that pretreatment AAPR could serve as a valuable and cost-effective prognostic indicator in HNC, potentially aiding clinicians in risk stratification and treatment decision-making. However, additional validation studies are warranted to confirm its clinical applicability.</p>\",\"PeriodicalId\":10318,\"journal\":{\"name\":\"Clinical and Experimental Otorhinolaryngology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-07-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Experimental Otorhinolaryngology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21053/ceo.2025-00034\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OTORHINOLARYNGOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Otorhinolaryngology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21053/ceo.2025-00034","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
Prognostic utility of albumin-to-alkaline phosphatase ratio in head and neck cancer: A systematic review and metaanalysis.
The prognostic value of pretreatment albumin-to-alkaline phosphatase ratio (AAPR) in head and neck cancer (HNC) remains controversial. This meta-analysis investigated AAPR's predictive potential for survival outcomes in HNC patients. We conducted a comprehensive literature search across EMBASE, Cochrane Library, and PubMed databases through July 30, 2024. Eight studies comprising 1737 HNC patients were analyzed using random-effects models. The analysis revealed that lower AAPR values were significantly correlated with worse overall survival (HR = 2.08), progression-free survival (HR = 2.00), and disease-free survival (HR = 2.18). Sensitivity analyses confirmed result robustness, with no significant publication bias detected. These findings suggest that pretreatment AAPR could serve as a valuable and cost-effective prognostic indicator in HNC, potentially aiding clinicians in risk stratification and treatment decision-making. However, additional validation studies are warranted to confirm its clinical applicability.
期刊介绍：
Clinical and Experimental Otorhinolaryngology (Clin Exp Otorhinolaryngol, CEO) is an international peer-reviewed journal on recent developments in diagnosis and treatment of otorhinolaryngology-head and neck surgery and dedicated to the advancement of patient care in ear, nose, throat, head, and neck disorders. This journal publishes original articles relating to both clinical and basic researches, reviews, and clinical trials, encompassing the whole topics of otorhinolaryngology-head and neck surgery.
CEO was first issued in 2008 and this journal is published in English four times (the last day of February, May, August, and November) per year by the Korean Society of Otorhinolaryngology-Head and Neck Surgery. The Journal aims at publishing evidence-based, scientifically written articles from different disciplines of otorhinolaryngology field.
The readership contains clinical/basic research into current practice in otorhinolaryngology, audiology, speech pathology, head and neck oncology, plastic and reconstructive surgery. The readers are otolaryngologists, head and neck surgeons and oncologists, audiologists, and speech pathologists.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
